Tvardi Therapeutics, Inc. (TVRD)
1.82
+0.02
(+1.11%)
USD |
NASDAQ |
Aug 28, 16:00
1.81
-0.01
(-0.55%)
After-Hours: 20:00
Tvardi Therapeutics Total Assets (Quarterly) : 17.52M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.52M |
| March 31, 2026 | 25.82M |
| December 31, 2025 | 32.07M |
| September 30, 2025 | 39.02M |
| June 30, 2025 | 43.75M |
| March 31, 2025 | 38.95M |
| December 31, 2024 | 35.20M |
| September 30, 2024 | 51.33M |
| June 30, 2024 | 72.50M |
| March 31, 2024 | 90.10M |
| December 31, 2023 | 125.84M |
| September 30, 2023 | 115.34M |
| June 30, 2023 | 134.39M |
| March 31, 2023 | 153.28M |
| December 31, 2022 | 182.24M |
| September 30, 2022 | 213.51M |
| June 30, 2022 | 226.57M |
| March 31, 2022 | 223.87M |
| December 31, 2021 | 247.06M |
| September 30, 2021 | 270.06M |
| June 30, 2021 | 221.45M |
| March 31, 2021 | 250.23M |
| December 31, 2020 | 271.16M |
| September 30, 2020 | 147.14M |
| June 30, 2020 | 168.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 196.17M |
| December 31, 2019 | 232.96M |
| September 30, 2019 | 263.80M |
| June 30, 2019 | 149.64M |
| March 31, 2019 | 170.59M |
| December 31, 2018 | 190.82M |
| September 30, 2018 | 212.70M |
| June 30, 2018 | 139.89M |
| March 31, 2018 | 80.64M |
| December 31, 2017 | 97.00M |
| September 30, 2017 | 108.05M |
| June 30, 2017 | 117.97M |
| March 31, 2017 | 129.82M |
| December 31, 2016 | 63.83M |
| September 30, 2016 | 80.15M |
| June 30, 2016 | 92.04M |
| March 31, 2016 | 102.01M |
| December 31, 2015 | 110.90M |
| September 30, 2015 | 117.90M |
| June 30, 2015 | 46.44M |
| March 31, 2015 | 51.65M |
| December 31, 2014 | 55.93M |
| September 30, 2014 | 62.37M |
| June 30, 2014 | 68.19M |
| March 31, 2014 | 71.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| Crinetics Pharmaceuticals, Inc. | 1.322B |
| Liquidia Corp. | 521.92M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.135M |
| Shareholders Equity (Quarterly) | 8.382M |
| Debt to Equity Ratio | 0.0173 |
| Current Ratio | 1.873 |
| Net Debt Paydown Yield | 51.25% |